(EMBARGO UNTIL MONDAY) Adequate Dosing of Hydroxychloroquine: Are Patients Getting Enough?
Dr. Sheila Reyes, The Phillipines
Abstract 1654.
A Year in Review
Dr. Jack Cush, Philadelphia
Differences in Clinical Presentation and Outcomes of Early vs Late Onset PsA
Dr. Olga Petryna, New York
Abstract 0377
mTORC1 as a Driver of Inflammation in sJIA Connecting Pathogens of sJIA and MAS
Dr. Olga Petryna, New York
Abstract 0004
Patient Reported Outcomes in PsA Using Novel IL 17A Inhibitor
Dr. Sims discusses abstract 0199 presented at ACR22 Convergence in Philadelphia, PA.
Abstract 0199: Izokibep, a Novel IL-17A Inhibitor, Improves Patient-reported Outcomes – 16-Week Results from a Placebo-controlled Phase 2 Study in Patients with Active Psoriatic Arthritis
The CONSUL Trial
Dr. Sheila Reyes, The Phillipines
Abstract 0526
What's Happening on the Hill?
Dr. Rachel Tate talks with Dr. Angus Worthing about ACR22 Convergence Session # 12S119 about legislative updates.